-
GENERIC ENTRY AND THE EARLY IMPACT ON U.S. PHARMACEUTICAL SPENDING
Mar 18, 2026, 21:38 PM -
FINANCIAL COSTS OF PROVIDING ORAL PRE- AND POST-EXPOSURE PROPHYLAXIS VIA PHARMACIES IN KENYA
Mar 18, 2026, 21:38 PM -
IMPACT OF LIPID-LOWERING THERAPIES ON TRIGLYCERIDE LEVELS IN US PATIENTS WITH ASCVD IN THE REAL-WORLD
Mar 18, 2026, 21:38 PM -
ATTRIBUTE MINING FOR DISCRETE CHOICE EXPERIMENTS ACROSS DISEASES USING GEN-AI: REPLICATION AND VALIDATION OBJECTIVES
Mar 18, 2026, 21:38 PM -
REAL-WORLD DOSING AND DISCONTINUATION OF HYPERTENSION THERAPIES: INSIGHTS FROM A NATIONAL PHARMACY DATABASE
Mar 18, 2026, 21:38 PM -
VALIDATION OF THE HEPARIN-INDUCED THROMBOCYTOPENIA DIAGNOSIS CODE USING A LARGE-SCALE ELECTRONIC HEALTH RECORD DATABASE
Mar 18, 2026, 21:38 PM -
TARGETED LITERATURE REVIEW TO IDENTIFY US CLAIMS-BASED ALGORITHMS FOR ALZHEIMER’S DISEASE
Mar 18, 2026, 21:38 PM -
INCREASING EFFICIENCY OF SYSTEMATIC LITERATURE REVIEWS: ARE MULTIPLE DATABASES NECESSARY?
Mar 18, 2026, 21:38 PM -
THE PATTERNS OF COUPON OFFSETS IN GLUCAGON-LIKE PEPTIDE AGONIST USE:EVIDENCE FROM NATIONAL, ALL-PAYER PHARMACY CLAIMS
Mar 18, 2026, 21:38 PM -
COMPARATIVE RISK OF PSYCHIATRIC OUTCOMES WITH GLP-1RAS ACROSS METABOLIC INDICATIONS: A POPULATION-BASED RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
MULTI-INDICATION BUDGET IMPACT ANALYSIS OF SUBCUTANEOUS IGPRO20 PRE-FILLED SYRINGES FOR THE TREATMENT OF PID, SID, AND CIDP IN ITALY
Mar 18, 2026, 21:38 PM -
EFFECT OF WOUND EXUDATE SEVERITY ON TIME TO COMPLETE HEALING IN DIABETIC FOOT ULCERS: A REAL-WORLD LONGITUDINAL ANALYSIS (EXACT STUDY)
Mar 18, 2026, 21:38 PM -
INTEGRATION OF PATIENT-REPORTED OUTCOME MEASURES IN LOWER URINARY TRACT SYMPTOMS ATTRIBUTED TO BENIGN PROSTATIC HYPERPLASIA (LUTS/BPH) CARE: QUALITATIVE INSIGHTS FOR IMPLEMENTATION STRATEGIES
Mar 18, 2026, 21:38 PM -
EARLY PATTERNS IN SECOND ORPHAN DRUG DESIGNATIONS FOLLOWING EXPANSION OF THE ORPHAN DRUG EXCLUSION
Mar 18, 2026, 21:38 PM -
A SEQUENTIAL MATCHING APPROACH TO ADDRESS IMMORTAL TIME BIAS: APPLICATION TO THE MGUS STUDY
Mar 18, 2026, 21:38 PM -
PREDICTORS OF PATIENT-DIRECTED DISCHARGE AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
A COST CALCULATOR FOR ESTIMATING DIRECT MEDICAL COST AVOIDANCE FROM SECOND-LINE SELADELPAR USE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Mar 18, 2026, 21:38 PM -
CHANGING THE RULES OF THE GAME: AN AI-DRIVEN GAME-THEORETIC ANALYSIS OF THE CAUSAL DRIVERS IN EARLY-ONSET MALIGNANCY
Mar 18, 2026, 21:38 PM -
BETA-BLOCKER USE AND BREAST CANCER OUTCOMES: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
COMPARATIVE VALUE-BASED PERFORMANCE ACROSS NUTRITION, PSYCHOLOGY, AND PHYSIOTHERAPY CARE PATHWAYS USING PATIENT-REPORTED OUTCOMES, EXPERIENCE, AND COST DATA
Mar 18, 2026, 21:38 PM